Christopher D. Andry, MPhil, PhD
Professor, Pathology & Laboratory Medicine
Biography
Christopher Andry, MPhil, PhD, was named Chief, Department of Pathology and Laboratory Medicine at Boston Medical Center (BMC) and Chair, Department of Pathology and Laboratory Medicine at Chobanian and Avedisian School of Medicine (BUSM) effective September 1, 2019. Dr. Andry’s career at BMC and BU has spanned more than 40 years, during which he has demonstrated a deep-rooted commitment to and passion for the mission of the BMC Health System, BUSM and the Medical Campus, Boston University and the Boston community at large. As Chief and Chair, Dr. Andry will bring his clinical expertise and leadership to the role to ensure a high-quality, integrated, academic department that is innovative, well-resourced, and collaborative.
Dr. Andry is a member of the BU-BMC Cancer Center Executive Committee, and liaison to New England Donor Services.
Dr. Andry is well recognized in the field of biospecimen science. In a team-based setting at BU and BMC, he has established evidence-based protocols and standards to ensure curation and distribution of high-quality, well-annotated biospecimens. Dr. Andry has served as the PI on more than $2 million in NCI funded grants and contracts to set standards for the science of biospecimen collection. Dr. Andry has raised the profile of BU in biobanking and provides the expertise for obtaining usable tissue samples for medical campus research faculty. Dr Andry is focused on supporting research and infrastructure to reduce healthcare disparities for underserved populations and has an interest in cancer biology, specifically prostate and breast cancer.
Dr. Andry received his PhD in pathology from BUSM and his bachelor of science and master of philosophy in biological sciences from the University of Lancaster, United Kingdom. He has published and collaborated on more than 50 articles, reviews and medical texts.
Other Positions
- Chair, Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine
- Chief, Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine
- Professor, Family Medicine, Boston University Chobanian & Avedisian School of Medicine
- Member, BU-BMC Cancer Center, Boston University
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Boston Medical Center
- Graduate Faculty (Primary Mentor of Grad Students), Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
Education
- Boston University, PhD
- Lancaster University, MPhil
- Lancaster University, BSc
Publications
- Published on 5/17/2023
Dodge MC, Ye L, Duffy ER, Cole M, Gawel SH, Werler MM, Daghfal D, Andry C, Kataria Y. Kinetics of SARS-CoV-2 Serum Antibodies Through the Alpha, Delta, and Omicron Surges Among Vaccinated Health Care Workers at a Boston Hospital. Open Forum Infect Dis. 2023 Jul; 10(7):ofad266. PMID: 37396669.
Read at: PubMed - Published on 11/2/2021
Ragan EJ, McCallum C, Marathe J, Cole M, Hofman M, Henderson AJ, Flack T, Miller NS, Burks EJ, Zhao GQ, Denis R, Lin NH, Jacobson KR, Andry CD, Pelton SI, Duffy ER, Bhadelia N. Pandemic Response Requires Research Samples: A U.S. Safety-Net Hospital's Experience and Call for National Action. Ann Intern Med. 2021 12; 174(12):1727-1732. PMID: 34724402.
Read at: PubMed - Published on 8/21/2021
Song J, Korunes-Miller J, Banerji R, Wu Y, Fazeli S, Zheng H, Orr B, Morgan E, Andry C, Henderson J, Miller NS, White A, Grinstaff MW. On-Site, On-Demand 3D-Printed Nasopharyngeal Swabs to Improve the Access of Coronavirus Disease-19 Testing. Glob Chall. 2021 Nov; 5(11):2100039. PMID: 34754507.
Read at: PubMed - Published on 5/6/2021
Kataria Y, Cole M, Duffy E, de la Cena K, Schechter-Perkins EM, Bouton TC, Werler MM, Pierre C, Ragan EJ, Weber SE, Jacobson KR, Andry C. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts. Sci Rep. 2021 05 06; 11(1):9694. PMID: 33958668.
Read at: PubMed - Published on 9/15/2020
Giadone RM, Mithal A, Miller GJ, Matte TM, Yeung AK, Dowrey TW, Werder RB, Miller NS, Andry CD, Vanuytsel K, Murphy GJ. qRT-PCR Platforms for Diagnosing and Reporting SARS-CoV-2 Infection in Human Samples. STAR Protoc. 2020 Sep 18; 1(2):100102. PMID: 32954369.
Read at: PubMed - Published on 7/1/2020
Selby R, Duffy ER, Berny-Lang MA, Andry CD, Lee AYY. Impact of specific preclinical variables on coagulation biomarkers in cancer-associated thrombosis. Thromb Res. 2020 07; 191 Suppl 1:S26-S30. PMID: 32736774.
Read at: PubMed - Published on 5/19/2020
Vanuytsel K, Mithal A, Giadone RM, Yeung AK, Matte TM, Dowrey TW, Werder RB, Miller GJ, Miller NS, Andry CD, Murphy GJ. Rapid Implementation of a SARS-CoV-2 Diagnostic Quantitative Real-Time PCR Test with Emergency Use Authorization at a Large Academic Safety Net Hospital. Med (N Y). 2020 Dec 18; 1(1):152-157.e3. PMID: 32838351.
Read at: PubMed - Published on 12/26/2019
Belghasem M, Roth D, Richards S, Napolene MA, Walker J, Yin W, Arinze N, Lyle C, Spencer C, Francis JM, Thompson C, Andry C, Whelan SA, Lee N, Ravid K, Chitalia VC. Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis. Blood. 2019 12 26; 134(26):2399-2413. PMID: 31877217.
Read at: PubMed - Published on 7/10/2019
Calner P, Sperring H, Ruiz-Mercado G, Miller NS, Andry C, Battisti L, Scrudder K, Shea F, Chan A, Schechter-Perkins EM. HCV screening, linkage to care, and treatment patterns at different sites across one academic medical center. PLoS One. 2019; 14(7):e0218388. PMID: 31291275.
Read at: PubMed - Published on 4/17/2019
Feng F, Thompson MP, Thomas BE, Duffy ER, Kim J, Kurosawa S, Tashjian JY, Wei Y, Andry C, Stearns-Kurosawa DJ. A computational solution to improve biomarker reproducibility during long-term projects. PLoS One. 2019; 14(4):e0209060. PMID: 30995241.
Read at: PubMed
View 22 more publications: View full profile at BUMC